Escitalopram treatment for depressive disorder following acute coronary syndrome / Jae-Min Kim en The Journal of Clinical Psychiatry, Año 2015 - Vol.76 - No.1 (Enero)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.1 (Enero) . - pp.62–68 Título : Escitalopram treatment for depressive disorder following acute coronary syndrome : A 24-week double-blind, placebo-controlled trial Tipo de documento: texto impreso Autores: Jae-Min Kim, Autor ; Kyung-Yeol Bae, Autor ; Robert Stewart, Autor Fecha de publicación: 2020 Artículo en la página: pp.62–68 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Síndrome coronario agudo, Citalopram, Trastorno depresivo, Inhibidores de la captación de serotonina. Resumen: Depression is common after acute coronary syndrome (ACS) and has adverse effects on prognosis. There are few evidence-based interventions for treating depression in ACS. This study investigated the efficacy and safety of escitalopram in treating depressive disorders identified 2–14 weeks after a confirmed ACS episode. Link: ./index.php?lvl=notice_display&id=21805 [artículo] Escitalopram treatment for depressive disorder following acute coronary syndrome : A 24-week double-blind, placebo-controlled trial [texto impreso] / Jae-Min Kim, Autor ; Kyung-Yeol Bae, Autor ; Robert Stewart, Autor . - 2020 . - pp.62–68. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.1 (Enero) . - pp.62–68 Palabras clave: Síndrome coronario agudo, Citalopram, Trastorno depresivo, Inhibidores de la captación de serotonina. Resumen: Depression is common after acute coronary syndrome (ACS) and has adverse effects on prognosis. There are few evidence-based interventions for treating depression in ACS. This study investigated the efficacy and safety of escitalopram in treating depressive disorders identified 2–14 weeks after a confirmed ACS episode. Link: ./index.php?lvl=notice_display&id=21805

---

1 (1 - 1 / 1)